Achillion Pharmaceuticals (ACHN)
Achillion Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -9.141M | -12.38M | -10.44M | -11.25M | -10.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.198M | 0.218M | 0.243M | 0.16M | 0.184M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.92M | 1.004M | 0.558M | 0.668M | 0.657M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 1.118M | 1.222M | 0.801M | 0.828M | 0.841M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -3.098M | 1.253M | 0.381M | 2.25M | 1.068M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -11.12M | -9.91M | -9.256M | -8.172M | -8.224M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.475M | -0.139M | -0.096M | -0.492M | -0.005M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 23.24M | 2.675M | -49.16M | -0.044M | 12.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 22.77M | 2.536M | -49.26M | -0.536M | 12.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | 0.574M | -0.034M | -0.034M | 0.438M | -0.478M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | 1.158M | 0.13M | 0.018M | 61.47M | 0.041M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | 0.00 | -0.008M | 0.00 | -0.01M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Cash from Financing Activities | 1.732M | 0.096M | -0.024M | 61.91M | -0.447M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | 13.38M | -7.278M | -58.54M | 53.20M | 3.348M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 16.11M | 25.37M | 16.11M | 23.39M | 81.92M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 29.49M | 16.11M | 23.39M | 81.92M | 28.72M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
